SELLAS Life Sciences Group, Inc.
corporate_fare Company Profile
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for SLS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Shareholders to Vote on Significant Increase in Equity Incentive Plan Shares
- SELLAS Life Sciences Establishes $150M At-The-Market Equity Offering Program
- SELLAS Life Sciences Reports Strong Cash Position and Imminent Phase 3 Trial Results
- SELLAS Life Sciences Reports Strong Liquidity & Positive Clinical Progress for SLS009, Addressing Going Concern
- SELLAS Life Sciences Secures $42.6M from Warrant Exercises, Boosting Liquidity
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$26.86M
Diluted EPS
-$0.25
Op. Cash Flow
-$28.39M
Operating Income
-$28.27M
Cash & Equivalents
$71.79M
Debt / Equity
0.00×
Shares Outstanding
153.1M sh
Source: 10-K · filed 2026-03-19 · accession 0001390478-26-000003
show_chartPrice Chart
Loading chart...
feed SLS - Filings & News (Page 2)
SLS
Apr 23, 2026, 4:10 PM EDT
Price at Filing:
$4.66
Real-time Price:
$14.21
Change:
+$9.55 (+205%)
Market Cap:
$2.785B
SLS
Mar 20, 2026, 5:01 PM EDT
Price at Filing:
$4.86
Real-time Price:
$14.21
Change:
+$9.35 (+192%)
Market Cap:
$2.785B
SLS
Mar 19, 2026, 4:08 PM EDT
Price at Filing:
$5.23
Real-time Price:
$14.21
Change:
+$8.98 (+172%)
Market Cap:
$2.785B
SLS
Mar 19, 2026, 4:00 PM EDT
Price at Filing:
$5.23
Real-time Price:
$14.21
Change:
+$8.98 (+172%)
Market Cap:
$2.785B
SLS
Mar 11, 2026, 4:06 PM EDT
Price at Filing:
$5.50
Real-time Price:
$14.21
Change:
+$8.71 (+158%)
Market Cap:
$2.785B
SLS
Jan 08, 2026, 8:30 AM EST
Price at Filing:
$4.00
Real-time Price:
$14.21
Change:
+$10.21 (+255%)
Market Cap:
$2.785B